Invex Therapeutics Balance Sheet Health

Financial Health criteria checks 4/6

Invex Therapeutics has a total shareholder equity of A$5.3M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$6.3M and A$984.6K respectively.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ration/a
CashAU$6.15m
EquityAU$5.30m
Total liabilitiesAU$984.57k
Total assetsAU$6.28m

Recent financial health updates

Recent updates

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Jun 09
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Jan 11
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

We Think Invex Therapeutics (ASX:IXC) Can Afford To Drive Business Growth

Aug 24
We Think Invex Therapeutics (ASX:IXC) Can Afford To Drive Business Growth

Companies Like Invex Therapeutics (ASX:IXC) Are In A Position To Invest In Growth

May 10
Companies Like Invex Therapeutics (ASX:IXC) Are In A Position To Invest In Growth

Companies Like Invex Therapeutics (ASX:IXC) Can Afford To Invest In Growth

Jan 25
Companies Like Invex Therapeutics (ASX:IXC) Can Afford To Invest In Growth

We're Interested To See How Invex Therapeutics (ASX:IXC) Uses Its Cash Hoard To Grow

Sep 27
We're Interested To See How Invex Therapeutics (ASX:IXC) Uses Its Cash Hoard To Grow

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Mar 31
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Should You Review Recent Insider Transactions At Invex Therapeutics Ltd (ASX:IXC)?

Feb 06
Should You Review Recent Insider Transactions At Invex Therapeutics Ltd (ASX:IXC)?

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Dec 15
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: IXC's short term assets (A$6.3M) exceed its short term liabilities (A$984.6K).

Long Term Liabilities: IXC's short term assets (A$6.3M) do not cover its long term liabilities (A$-1.0).


Debt to Equity History and Analysis

Debt Level: IXC is debt free.

Reducing Debt: IXC has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IXC has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: IXC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 42.6% each year


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.